Key benefits of Octet biosensor technology for AAV capsid titer analysis

In this application note, Sartorius presents the key benefits of its Octet^® biosensor technology. These benefits include reducing time-to-results by 80% compared to ELISA, enabling near real-time decision-making, reducing operator hands-on time by 50%, and decreasing sample preparation time by 15-25%. The Octet^® system is a robust analytical tool for mAb characterization, and the Octet^® AAV2 assay offers a simple workflow for AAV titer analysis with high-throughput capabilities and accurate results that correlate well with ELISA and ddPCR™.